SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-130160
Filing Date
2022-12-27
Accepted
2022-12-27 16:01:37
Documents
12
Period of Report
2022-12-23
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2233381d1_8k.htm   iXBRL 8-K 25320
  Complete submission text file 0001104659-22-130160.txt   197982

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA isee-20221223.xsd EX-101.SCH 3039
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE isee-20221223_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE isee-20221223_pre.xml EX-101.PRE 22599
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2233381d1_8k_htm.xml XML 3477
Mailing Address 8 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 8 SYLVAN WAY PARSIPPANY NJ 07054 (609) 474-6755
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

IRS No.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36080 | Film No.: 221490308
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences